Skip to main content

Why are the billionaires always laughing?

Because they know the corporate media will never call bullshit on their bullshit.

Why are the billionaires laughing?

It’s easy to laugh when the corporate press treats you as a glorious success instead of the epitome of a broken social order. Billionaires laugh because they know the corporate media prefers to fawn over them rather than hold them to account.

Today, we ask you to support our nonprofit, independent journalism because we are not impressed by billionaires flying into space, their corporations despoiling our health and planet, or their vast fortunes safely concealed in tax havens across the globe. We are not laughing.

We are hard at work producing journalism for the common good. With our Fall Campaign underway, please support this mission today. We cannot do it without you.

Support Our Work -- Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Every donation—large or small—helps us bring you the news that matters.

Moncef Slaoui, former head of GlaxoSmithKline's vaccine division, has reportedly been named to lead "Operation Warp Speed," the Trump administration's program aimed at developing a Covid-19 vaccine. (Photo: C-Span)

Government Watchdog Sounds Alarm Over Appointment of Former Pharma Executive to Trump's Covid-19 Vaccine Task Force

"If the Trump administration approaches vaccine development as it has Covid-19 prevention, testing and treatment, the world may be in for years of more extraordinary pain," said Public Citizen. 

Julia Conley

Government watchdog Public Citizen on Thursday condemned the Trump administration's reported appointment of a former pharmaceutical executive to the White House's task force aimed at swiftly developing a Covid-19 vaccine as another example of the White House putting management of the pandemic in the hands of private industry. 

The administration named Moncef Slaoui, former head of GlaxoSmithKline's vaccine division and a venture capitalist in the pharmaceutical field, to act as chief adviser for the program, called "Operation Warp Speed."

Slaoui worked at GlaxoSmithKline for 30 years until 2017, and since then has sat on the boards of a number of pharmaceutical firms which are now researching potential vaccines for the coronavirus—leaving the former executive with what Public Citizen called "blatant financial conflicts of interest."

Currently a partner at pharmaceutical investment firm Medicxi, Slaoui has earned $490,000 as a board member at Moderna, Inc. and also sits on the board of Lonza Group AG, a Swiss company which is contracting with Moderna to find a Covid-19 vaccine. His former employer, GlaxoSmithKine, is also working to develop an immunization.

According to Bloomberg, Slaoui plans to leave the boards that he currently sits on, but Public Citizen demanded confirmation from the former executive that he will commit to finding a vaccine that is made available globally, regardless of the profits his companies stand to lose or gain. 

Slaoui's current and former positions in the pharmaceutical industry should "disqualify" him," said Peter Maybarduk, director of Public Citizen's Access to Medicines program, "unless he commits immediately to global vaccine access conditions over the obvious profit interests of the corporations he serves."

"If the Trump administration approaches vaccine development as it has Covid-19 prevention, testing, and treatment, the world may be in for years of more extraordinary pain," Maybarduk added. "The dangers of global vaccine rationing are profound. No one corporation has the capacity to deliver a vaccine to all the world's people."

Earlier this week, Public Citizen noted, Slaoui denied to Politico that he was being considered for the administration's program, saying, "I'm the same venture capitalist you talked to last week."

Now, said Maybarduk, Slaoui must prove the opposite is true.

With Operation Warp Speed, the administration plans to bring together pharmaceutical companies and government agencies to cut the development time for a Covid-19 vaccine by several months, with officials hoping an immunization will be developed by the end of 2020. 

In March, Trump's FDA came under fire for awarding monopoly status to Gilead Sciences for Remdesivir, a drug it was developing for Covid-19 treatment. The company backed off its claim after a pressure campaign led by Public Citizen. 

"The U.S. government must commit to sharing clinical trial data, patents, and know-how among manufacturers and with the world, to quickly achieve the mountainous scale of production that humanity needs," the group said.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

'It's Not Coming Out': Bernie Sanders Stands Firm on Medicare Expansion

"It's what the American people want and, after waiting over 50 years, what they are going to get."

Julia Conley ·


'When We Organize, We Win': Ocasio-Cortez Joins India Walton at Rally in Buffalo

The two progressives joined striking hospital workers on the picket line at Mercy Hospital after the early voting rally.

Julia Conley ·


Fatal Film Set Shooting Followed Outcry by Union Crew Members Over Safety Protocols

"When union members walk off a set about safety concerns, maybe 'hiring scabs' isn’t the solution you think it is."

Julia Conley ·


New Whistleblower Sparks Calls to 'Crack Down on Facebook and All Big Tech Companies'

Hours after another ex-employee filed a formal complaint, reporting broke on internal documents that show the tech giant's failure to address concerns about content related to the 2020 U.S. election.

Jessica Corbett ·


'Catastrophic and Irreparable Harm' to Wolves Averted as Wisconsin Judge Cancels Hunt

"We are heartened by this rare instance of reason and democracy prevailing in state wolf policy," said one conservation expert.

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo